Found: 11
Select item for more details and to access through your institution.
The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 4, p. 919, doi. 10.1093/jac/dkn013
- By:
- Publication type:
- Article
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2007, v. 59, n. 3, p. 565, doi. 10.1093/jac/dkl497
- By:
- Publication type:
- Article
Cryoglobulinemia-Related Vasculitis During Effective Anti-HCV Treatment with PEG-Interferon alfa-2b.
- Published in:
- Infection, 2008, v. 36, n. 3, p. 285, doi. 10.1007/s15010-007-6299-1
- By:
- Publication type:
- Article
A randomized trial of pegylated-interferon- α2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2006, v. 24, n. 7, p. 1079, doi. 10.1111/j.1365-2036.2006.03098.x
- By:
- Publication type:
- Article
Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study.
- Published in:
- Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 850, doi. 10.1111/jvh.12711
- By:
- Publication type:
- Article
Sequential therapy with entecavir and peginterferon alpha in chronic hepatitis B: for many but not for all?
- Published in:
- Journal of Viral Hepatitis, 2016, v. 23, n. 5, p. 402, doi. 10.1111/jvh.12502
- By:
- Publication type:
- Article
Role of CYP27 B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBe Ag negative with PEG-interferon.
- Published in:
- Journal of Viral Hepatitis, 2015, v. 22, n. 3, p. 318, doi. 10.1111/jvh.12288
- By:
- Publication type:
- Article
Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir.
- Published in:
- Journal of Viral Hepatitis, 2014, v. 21, n. 4, p. 260, doi. 10.1111/jvh.12170
- By:
- Publication type:
- Article
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non- D genotypes.
- Published in:
- Journal of Viral Hepatitis, 2013, v. 20, n. 4, p. e11, doi. 10.1111/jvh.12018
- By:
- Publication type:
- Article
A short course of pegylated interferon- α in acute HCV hepatitis.
- Published in:
- Journal of Viral Hepatitis, 2007, v. 14, n. 2, p. 116, doi. 10.1111/j.1365-2893.2006.00802.x
- By:
- Publication type:
- Article
Risk Factors and Outcome among a Large Patient Cohort with Community-Acquired Acute Hepatitis C in Italy.
- Published in:
- Clinical Infectious Diseases, 2006, v. 43, n. 9, p. 1154, doi. 10.1086/507640
- By:
- Publication type:
- Article